AbdallahGKfouryMDFACC

PubMed

• Integration of Patient Reported Quality-of-life Data into Risk Assessment in Heart Failure.
  Konstantinos Sideris, Mingyuan Zhang, Peter Wohlfahrt, Alfonso F Siu, Jincheng Shen
  Journal of Cardiac Failure. 2024-09-18
• Donor Age, Sex, and Cause of Death and Their Relationship to Heart Transplant Recipient Cardiac Death.
  Margo E Hammond, Charles Zollinger, Andrija Vidic, Gregory L Snow, Joseph Stehlik
  Journal of Clinical Medicine. 2023-12-12
• 26 citations
  Right Heart Failure Following Left Ventricular Device Implantation: Natural History, Risk Factors, and Outcomes: An Analysis of the STS INTERMACS Database.
  Chris J Kapelios, Lars H Lund, Omar Wever-Pinzon, Craig H Selzman, Susan L Myers
  Circulation. Heart Failure. 2022-06-01

Journal Articles

• Health Related Quality of Life in Heart Failure Patients with Improved Ejection Fraction  
  Omar Wever-Pinzon, Stavros Drakos, Line Kemeyou, Abdallah G Kfoury, Josef Stehlik, Journal of Cardiac Failure
• Spironolactone for heart failure with preserved ejection fraction  
  Pitt B, Pfeffer MA, Assmann SF, Boineau R, Anand IS, Claggett B, Clausell N, Desai AS, Diaz R, Fleg JL, Gordeev I, Harty B, Heitner JF, Kenwood CT, Lewis EF, O'Meara E..., N Engl J Med, 4/1/2014
• Utility of Gene Expression Profiling Test Score Variability to Predict Future Clinical Events in Heart Transplant Recipients  
  Deng MC, Elashoff B, Pham MX, Teuteberg JJ, Kfoury AG, Starling RC, Cappola TP, Kao A, Anderson AS, Cotts WG, Ewald GA, Baran DA, Bogaev RC, Shahzad K, Yee J, and Vala..., Transplantation, 1/1/2014
• Survival Based on Patient Selection for Heart Transplant in Adults with Congenital Heart Disease: A Multi-Institutional Study  
  Boucek D, Yetman AT, Yeung E, Miyamoto SD, Stehlik J, Kfoury AG, Kaza AK, Weng C, Everitt MD, Int J Cardiol, 1/1/2014
• Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial  
  Chen HH, Anstrom KJ, Givertz MM, Stevenson LW, Semigran MJ, Goldsmith SR, Bart BA, Bull DA, Stehlik J, LeWinter MM, Konstam MA, Huggins GS, Rouleau JL, O'Meara E, Tang..., JAMA, 12/1/2013
• Interleukin Receptor family Member ST2 Concentrations, Allograft Rejection and Long-term Survival Following Heart Transplantation  
  Januzzi JL, Horne BD, Moore SA, Galenko O, Snow GL, Brunisholz KD, Muhlestein JB, Alharethi RA, Carlquist JF, Budge D, Rasmussen KD, Kfoury AG, Biomarkers, 5/1/2013
• Pulsatility and the Risk of Non-Surgical Bleeding in Patients Supported With the Continuous-Flow Left Ventricular Assist Device HeartMate II  
  Wever-Pinzon O, Selzman CH, Stoddard GJ, Saidi A, Drakos SG, Labedi M, Reid BB, Gilbert EM, Davis ES, Kfoury AG, Li DY, Stehlik J, Bader FM, Circ Heart Failure, 5/1/2013
• Magnitude and Time Course of Changes Induced by Continuous-Flow Left Ventricular Assist Device Unloading in Chronic Heart Failure: Insights into Cardiac Recovery  
  Drakos SG, Wever-Pinzon O, Stehlik J, Selzman CH, Reid BB, Gilbert EM, Alharethi RA, Movsesian M, Budge D, Stoker S, Davis ES, Li DY, Kfoury AG, J Am Coll Cardiol, 5/1/2013
• Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial  
  Redfield MM, Chen HH, Borlaug BA, Semigran MJ, Lee KL, Lewis G, LeWinter MM, Rouleau JL, Bull DA, Mann DL, Deswal A, Stevenson LW, Givertz MM, Ofili EO, O'Connor CM, F..., JAMA, 3/1/2013
• Electromagnetic interference of automatic implantable cardioverter defibrillator and HeartWare left ventricular assisting device  
  Labedi MR, Alharethi RA, Kfoury AG, Budge D, Reid BB, Rasmusson BY, Bunch JT, ASAIO, 1/1/2013
• Morbidity and Mortality in Heart Transplant Candidates Supported with Mechanical Circulatory Support Is Reappraisal of the Current UNOS Thoracic Organ Allocation Polic...  
  Wever-Pinzon O, Drakos SG, Kfoury AG, Nativi JN, Selzman CH, Everitt MD, Alharethi RA, Brunisholz KD, Bader FM, Li DY, Stehlik, Circulation, 1/1/2013
• Reply to Letter to the Editor: Left ventricular assist devices in chronic heart failure: more questions than answers?  
  Wever-Pinzon O, Kfoury AG, Selzman CH, Li DY, Stehlik J, Drakos SG, J Am Coll Cardiol, 1/1/2013
• Immune Function Surveillance: Association with Rejection, Infection and Allograft Vasculopathy  
  Heikal NM, Delgado JC, Martins TB, Pavlov IY, Wilson AR, Barakat M, Stehlik J, Kfoury AG, Gilbert EM, Hammond MEH, Bader FM, Hill HR, Transplant Proc, 1/1/2013
• Everolimus versus Mycophenolate in Heart Transplantation: A randomized multicenter trial  
  Eisen H, Kobashigawa JA, Starling R, Pauly D, Kfoury AG, Ross H, Wang SS, Cantin B, Van Bakel A, Ewald G, Hirt S, Lehmkuhl H, Keogh A, Rinaldi M, Potena L, Zuckermann ..., Am J Transplant, 1/1/2013
• NHLBI Working Group: Heart Transplantation Research in the Next Decade – A Goal to Achieving Evidence-Based Outcomes  
  Shah MR, Starling RC, Longacre LS, Mehra MR, (Kfoury AG) on behalf of the Working Group Participants, J Am Coll Cardiol, 1/1/2012
• Longitudinal Evaluation of Microvessel Density in Survivors versus Non-survivors of Cardiac Pathologic Antibody-mediated Rejection  
  Revelo MP, Miller DV, Stehlik J, Brunisholz K, Drakos SG, Gilbert EM, Everitt MD, Budge D, Alharethi RA, , Snow, G, Hammond MEH, Kfoury AG, Cardiovasc Pathology, 1/1/2012
• Biopsy-diagnosed antibody-mediated rejection based on the proposed International Society for Heart and Lung Transplantation working formulation portends adverse cardio...  
  Everitt MD, Hammond MEH, Snow GL, Stehlik J, Revelo MP, Miller DV, Molina KM, Kaza AK, Budge D, Alharethi RA, Kfoury AG, J Heart Lung Transplant, 1/1/2012
• Peripartum Cardiomyopathy: Post-transplant Outcomes from the United Network for Organ Sharing (UNOS) Database  
  Rasmusson KD, Brunisholz KD, Budge D, Horne BD, Alharethi RA, Folsom J, Connolly JJ, Stehlik J, Kfoury AG, J Heart Lung Transplant, 1/1/2012
• Ultrafiltration in Decompensated Heart Failure with Cardiorenal Syndrome  
  Bart BA, Goldsmith SR, Lee KL, Givertz MM, O'Connor CM, Bull DA, Redfield MM, Deswal A, Rouleau JL, LeWinter MM, Ofili EO, Stevenson LW, Semigran MJ, Felker GM, Chen H..., N Engl J Med, 1/1/2012
• Impact of High-dose Inotropic Support on Early Myocardial Necrosis and Outcomes in Cardiac Transplantation  
  Nixon JL, Kfoury AG, Brunisholz K, Horne BD, Myrick C, Miller DV, Budge D, Bader F, Everitt M, Revelo P, Stehlik J, Schmidt TC, Alharethi R, Clin Transplantation, 10/1/2011
• Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomized controlled trial  
  Abraham WT, Adamson PB, Bourge RC, Aaron MF, Costanzo MR, Stevenson LW, Strickland W, Neelagaru S, Raval N, Krueger S, Weiner S, Shavelle D, Jeffries B, Yadav JS; (Kfo..., Lancet, 1/1/2011
• Clinical and Hemodynamic Effects of Renin Angiotensin System Blockade in Cardiac Transplant Recipients  
  Karabsheh S, Verma DR, Jain M, Stoddard G, Stehlik J, Kfoury AG, Gilbert EM, Bader FM, Am J Cardiology, 1/1/2011
• Impact of Donor Left Ventricular Hypertrophy on Survival after Heart Transplant  
  Wever-Pinzon O, Stoddart G, Bader FM, Drakos SG, Selzman CH, Budge D, Alhareti RA, Nativi JN, Gilbert EM, Kfoury AG, Reid BB, Stehlik J, Am J Transplant, 1/1/2011
• Allograft Rejection in Patients Supported with Continuous-Flow Left Ventricular Assist Devices  
  Healy AH, Mason NO, Hammond MEH, Reid BB, Kfoury AG, Patel AN, Bull DA, Bader FM, Gilbert EM, Stehlik J, Selzman CH, Ann Thoracic Surgery, 1/1/2011
• Genome-wide Significance and Replication of the Chromosome 12p1122 Locus near PTHLH for Peripartum Cardiomyopathy  
  Horne BD, Rasmusson KD, Alharethi R, Budge D, Brunisholz KD, Metz T, Carlquist JF, Connolly JJ, Porter TF, Lappe DL, Muhlestein JB, Silver R, Stehlik J, Park JJ, May H..., Circ Cardiovasc Genet, 1/1/2011
• Join now to see all

Books/Book Chapters

• Heart Failure: A Comprehensive Guide to Pathophysiology and Clinical Care. 
  Chapter: Antibody-Mediated Rejection. 
  Kfoury AG, Budge D, Brunisholz KD, Hammond MEHEditors: Eisen H.Springer Science + Business Media, Narberth, PA2013
• Evidence-Based Cardiology Consult. 
  Chapter: Peripartum Cardiomyopathy. 
  Kfoury AG, Rasmusson KD, Brunisholz KD, Porter F, Horne BDEditors: Stergiopoulos K, Brown D.Springer Science + Business Media, Narberth, PA2013
• Cardiac Intensive Care 
  Chapter: Cardiac Transplantation. 
  Page 586 - 597Renlund DG, Rasmusson BY, Fisher PW, Kfoury AGSaunders Elsevier, Philadelphia, PA2010
• ISHLT Monograph Series, Advanced Heart Failure 
  Chapter: Supportive and end of life care. 
  Page 601 - 613Renlund DG, Brush SJ, Rasmusson KD, Kfoury AGElsevier, Philadelphia, PA2009
• Pacing to Support the Failing Heart 
  Chapter: Clinical outcomes and chronic management of device patients. 
  Page 297 - 318Fisher PW, Renlund DG, Kfoury AGEditors: Ellenbogen K, Auricchio A.Wiley-Blackwell, Publishers; Copyright: American Heart Association, Dallas, TX2008
• AST Primer on Transplantation 
  Chapter: Maintenance immunosuppression protocols for heart transplantation. 
  Page 382 - 386Taylor DO, Renlund DG, Kfoury AG2000
• Therapeutic Immunology. 
  Chapter: Cardiac Transplantation: Recipient selection and management. 
  Page 474 - 481Kfoury AG, Taylor DO, Renlund DGBlackwell Science, Cambridge, MA2000
• Join now to see all

Abstracts/Posters

• Determinants of waiting list time for heart transplantation: is it all about sensitization?
  McCubrey RO, Alharethi RA, Horne BD, Stehlik J, Reid BB, Everitt MD, Drakos SG, Budge D, Nativi J, Nixon JL, Fang JC, Caine WT, Kfoury AG, J Cardiac Failure, 1/1/2014
• Discrete-event Simulation (DES) to Evaluate and Improve the Performance of an Advanced Heart Failure/Transplant Clinic: a Real-life Experience.
  Kfoury AG, Rasmusson KD, Folsom JM, Budge D, Nixon JL, Alharethi RA, Lappe DL, LeBaron HT, J Cardiac Failure, 1/1/2014
• Late Antibody-mediated Rejection (AMR) in Heart Transplantation: How “Late” Is It?
  Nixon JL, Snow G, Budge D, Hammond ME, Stehlik J, Reid BB, Alharethi RA, Miller DV, Everitt MD, McKellar S, Revelo PM, Fang JC, Kfoury AG, J Cardiac Failure, 1/1/2014
• Learning from Heart Failure Patients to Improve Patient Centered Care.
  Rasmusson KD, Croasdell S, Meegan S, Nixon JL, Kfoury AG, Lappe DL, Roberts C, Budge D, J Cardiac Failure, 1/1/2014
• A Novel Model to Predict the Risk of Non-Surgical Bleeding Among Patients Receiving Continuous Flow Left Ventricular Assist Devices.
  Wever-Pinzon J, Wever-Pinzon O, Mckellar S, Badger C, Fang J, Drakos SG, Gilbert EM, Everitt MD, Alharethi RA, Budge D, Stehlik J, Kfoury A, Selzman C, Nativi-Nicolau J, J Heart Lung Transplant, 1/1/2014
• Cardiac metabolism gene expression differences in patients with advanced ischemic versus non-ischemic cardiomyopathy.
  Yen CG, Diakos N, Selzman CH, Reid BB, Stehlik J, Kfoury AG, Guo X, Navankasattusas S, Caine WT, McKellar S, Gilbert EMG, Fang JC, Budge D, Li DY, Drakos SG, J Heart Lung Transplant, 1/1/2014
• Circulating levels of miR-15b and MiR-133b in patients during chronic LVAD unloading.
  Galenko O, Kfoury AG, Selzman CH, Stehlik J, Diakos N, Yen CG, Wever-Pinzon O, Reid BB, Peterson H, Knight S, Alharethi RA, Budge D, Nativi-Nicolau J, McKellar S, Li D..., J Heart Lung Transplant, 1/1/2014
• Comparative Utility of Gene Expression Profiling Score Variability, Endomyocardial Biopsy, and Echocardiography to Predict Future Clinical Events in Heart Transplant R...
  Deng M, Kfoury AG, Teuteberg JT, Elashoff B, Hiller D, Yee J, Valantine HA, J Heart Lung Transplant, 1/1/2014
• Continuous-flow ventricular assist devices impact on failing heart’s vasculature.
  Yen CG, Diakos NA, Stehlik J, Selzman CH, Kfoury AG, Reid BB, Everitt MD, Wever-Pinzon O, Myrick C, Salama M, Hammond MEH, Symonds JD, Li DY, Drakos SG, J Heart Lung Transplant, 1/1/2014
• Do Continuous Flow Left Ventricular Assist Devices Really Cause Allosensitization?
  Willis C, Eckels D, Wever Pinzon O, Kfoury AG, Drakos SG, Alharethi RA, Nativi- Nicolau J, Budge D, Fang JC, Gilbert EMG, Selzman CH, Stehlik J, J Heart Lung Transplant, 1/1/2014
• Hoe does donor specific antibody relate to biopsy-diagnosed antibody-mediated rejection after pediatric heart transplantation?
  Ware A, Snow G, Hammond MEH, Miller DV, Stehlik J, Kfoury AG, Eckhauser A, Eckels D, Everitt MD, J Heart Lung Transplant, 1/1/2014
• Impact of Donor and Recipient Socio-economic Status on Outcomes in Adult Heart Transplantation: Does it Really Matter?
  Nixon JL, McCubrey RO, Budge D, Gilbert EMG, Alharethi RA, Reid BB, Drakos SG, Everitt MD, Stehlik J, Molina K, Fang JC, Doty J, Kfoury AG, J Heart Lung Transplant, 1/1/2014
• Improving Prothrombin Time International Normalized Ratio (INR) Control in Left Ventricular Assist Device (LVAD) Patients with Computerized Decision Support.
  Nixon JL, Budge D, Stoker S, Caine WT, Alharethi RA, Smith H, Reid BB, Thomsen G, Clayson SE, Goddard MK, Doty J, Kfoury AG, J Heart Lung Transplant, 1/1/2014
• Left Ventricular (LV) Response to Unloading by Continuous-flow Left Ventricular Assist devices (LVAD): Axial vs. Centrifugal?
  Rauf A, Johnson AK, Wright GA, Stoker S, Reid BB, Caine WT, Goddard MK, Alharethi RA, Thomsen GE, Budge D, Clayson SE, Rasmusson BY, Kfoury AG, J Heart Lung Transplant, 1/1/2014
• Mortality after readmission among heart failure patients.
  Benuzillo JG, Rasmusson KD, Kfoury AG, Nixon JL, Budge D, Alharethi RA, Roberts CA, Horne BD, Lappe DL, J Heart Lung Transplant, 1/1/2014
• Outcomes of patients referred for a left ventricular assist device but were declined: the recent-era forgotten ones.
  Johnson AK, McCandless SP, Alharethi RA, Caine WT, Budge D, Wright GA, Rauf A, Stoker S, Reid BB, Rasmusson BY, Kfoury AG, J Heart Lung Transplant, 1/1/2014
• Recovery of myocardial capillary bed (microvascular) density persists in long term follow up of CAV patients treated with sirolimus.
  Revelo MP, Miller DV, Wever-Pinzon J, Nixon JL, Hammond MEH, Stehlik J, Gilbert EMG, Fang JC, Everitt MD, Drakos SG, Budge D, Alharethi RA, Kfoury AG, J Heart Lung Transplant, 1/1/2014
• Structural remodeling of the cardiac ventricles: when left isn’t equally right.
  Diakos N, Barney J, Yen C, Stehlik J, Kfoury AG, Selzman CH, Reid BB, Wever-Pinzon O, Saidi A, Wright S, Koliopoulou A, Russell C, McCreath L, Fang JC, Li DY, Drakos SG, J Heart Lung Transplant, 1/1/2014
• TNF as a predictor of myocardial functional improvement induced by left ventricular mechanical unloading.
  Diakos N, Yen C, Wever-Pinzon O, Selzman CH, Reid BB, Stehlik J, Kfoury AG, Alharethi RA, Nativi J, Catino A, Davis C, Barney J, Wright S, Koliopoulou A, Fang JC, Li ..., J Heart Lung Transplant, 1/1/2014
• Assessment of anticoagulation management as a measurement of pump thrombus risk.
  G.A. Wright, A.G. Kfoury, S.P. McCandless, R.A. Merchel, A.K. Carter, S. Stoker, B.B. Reid, W.T. Caine, S.E. Clayson, R. Alharethi, ASAIO J, 5/1/2013
• Association between left ventricular assist device (LVAD) driveline exit site healing and post-implant hematocrit levels.
  A.K. Carter, B.B. Reid, R.A. Merchel, W.T. Caine, S.P. McCandless, S.E. Clayson, G.A. Wright, B. Rasmusson, S. Stoker, D. Budge, R. Alharethi, A.G. Kfoury, ASAIO J, 5/1/2013
• Characterizing left ventricular assist device parameters for early thrombus detection.
  S.P. McCandless, D.V. Miller, B.B. Reid, R. Alharethi, R.A. Merchel, D. Budge, S. Stoker, S.E. Clayson, A.K. Carter, G.A. Wright, W.T. Caine, A.G. Kfoury, ASAIO J, 5/1/2013
• Clinical comparison of the Centrimag and the Rotaflow centrifugal flow devices.
  A.K. Carter, S.S. Froebe, B.B. Reid, S.P. McCandless, R.A. Merchel, G.A. Wright, M. Goddard, S.E. Clayson, R. Alharethi, W.T. Caine, D. Budge, B. Rasmusson, S. Stoker,..., ASAIO J, 5/1/2013
• Incidence and characteristics of vascular complications with short-term VAD support.
  A.K. Carter, J. Revenaugh, R.A. Merchel, B.B. Reid, W.T. Caine, S.P. McCandless, S.E. Clayson, G.A. Wright, B. Rasmusson, S. Stoker, D. Budge, R. Alharethi, A.G. Kfoury, ASAIO J, 5/1/2013
• Veno-venous extracorporeal membrane oxygenation support after total artificial heart implantation.
  S.P. McCandless, B.B. Reid, M. Goddard, R. Alharethi, D. Budge, S. Stoker, S. Froebe, B. Rasmusson, W.T. Caine, G.A. Wright, A.K. Carter, S.E. Clayson, A.G. Kfoury, ASAIO J, 5/1/2013
• Join now to see all

Lectures

• Outcomes and considerations in the management of mixed rejection. Invited Speaker 
  San Diego, CA - 4/10/2014
• Treatment strategies for desensitization. Invited Speaker 
  San Diego, CA - 4/10/2014
• LVADs for Destination Therapy: Patient selection and cardiology perspective. 
  Salt Lake City, UT - 1/1/2014
• Heart Failure, Lecturer 
  University of Utah School of Medicine - 1/1/2014
• Pretransplant antibodies in clinical practice: Are they all bad, when to treat and use of the virtual crossmatch. Invited Speaker, Symposium 26 
  Montreal, Canada - 4/24/2013
• Should sensitization warrant higher priority on the waiting list? (CON). Invited Speaker, Great Debates in MCS, Symposium 19 
  Montreal, Canada - 4/24/2013
• The DEFs of AMR: Detecting the antibodies, Evaluating the biopsy, and Finally, the patient. Invited Speaker, Pre-meeting Symposium 14 
  Prague, Czech Republic - 4/18/2012
• Clinical spectrum and presentation of AMR. State of the Art Lecture 
  Vancouver, Canada - 8/16/2010
• Antibody-mediated rejection - clinical. Invited Speaker 
  Bethesda, MD - 8/5/2010
• Antibody-mediated rejection in heart transplantation: What works and what does not. Session Moderator 
  San Diego, CA - 5/3/2010
• Clinical presentation and management of antibody-mediated rejection in heart transplantation. Invited Speaker 
  San Diego, CA - 5/2/2010
• Clinical perspective of AMR. Invited Speaker 
  Chicago, IL - 4/21/2010
• Do we acknowledge and treat asymptomatic AMR? Invited Speaker 
  Chicago, IL - 4/20/2010
• Diagnosis of AMR - controversies and implications from the clinicians (medical-surgical) point of view. Invited Speaker 
  8/12/2009
• Clinical Parameters that Define Cardiac AMR in Adults. Invited Speaker 
  Paris, France - 4/22/2009
• Controversies in the Pathology and Clinical Significance of Antibody-mediated Rejection in Heart Transplantation. Keynote Address 
  Tokyo, Japan - 10/18/2008
• Trends in Immunosuppression in Heart Transplantation: Tacrolimus and Mycophenolate Mofetil. Invited Special Lecture 
  Tokyo, Japan - 10/18/2008
• Update on Heart Failure: How to get patients on Optimal Drugs. 
  Midway, UT - 10/1/2008
• Cardiac Transplantation: A brief history and 2008 update. 
  Intermountain Medical Center, Murray, UT - 2/13/2008
• Updates in heart failure management: What medicines should my patients be on? 
  Salt Lake City, UT - 2/24/2007
• 2006 Practical medical and device management of heart failure. 
  Utah Valley Regional Medical Center, Provo, UT - 8/21/2006
• How to get patients on optimal heart failure medications. 
  San Diego, CA - 8/12/2006
• Heart failure medical management: 2006 practical update. 
  Scottsdale, AZ - 3/25/2006
• Practical update on medical and emerging device therapies for heart failure. 
  Saint George, UT - 10/25/2005
• Inpatient management of heart failure: Which drug, when, and how much? 
  Midway, UT - 10/7/2005
• Join now to see all

Other

• Co-deposition of C4d and C3d in Cardiac Transplant Biopsies is Associated with Greater Cardiovascular Mortality Compared to Either Alone. 
  Miller DV, Revelo MP, Hammond MEH, Stehlik J, Gilbert EM, Bader FM, Everitt MD, Budge D, Alharethi RA, Kfoury AG
  http://cybernephrology.ualberta.ca/banff/2011/submittedabstracts.htm
  1/1/2011
• Characterization of the Failing Human Heart via Diffusion Tensor Imaging: an Ex-Vivo Study with Histological Correlation. 
  Abdullah OM, Drakos SG, Kfoury AG, Selzman CH, Stehlik J, Reid BB, Diakos NA, Brunisholz KD, Pinzon OW, Verma DR, Myrick C, Li DY, Hsu EW, wileyonlinelibrary.com
• The Effect of Ultraviolet Radiation on Thoratec (c) HeartMate II Driveline Material. 
  Carter AK, Horne BD, Reid BB, Alharethi RA, Budge D, Merchel RA, Caine WT, McCandless SP, Clayson SE, Wright GA, Rasmusson BY, Stoker S, Brunisholz KD, Kfoury AG
  http://journals.lww.com/asaiojournal/Documents/MAT_ABSTRACTS(3).pdf